Group 1 - Jiangsu Province's Human Resources and Social Security Department announced the list of new doctoral innovation practice bases for 2025, with Suzhou Haofan Bio Co., Ltd. and Suzhou Shuang'en Intelligent Technology Co., Ltd. successfully selected due to their strong research capabilities and talent cultivation systems [1] - Haofan Bio, a national high-tech enterprise, specializes in the field of biological reagents, offering products such as peptide synthesis reagents, molecular building blocks, protein reagents, and liposomal drug delivery systems, providing core support for the biopharmaceutical industry [1] - The company has a research team of over 140 members, including 5 PhDs and 2 national-level talents, holds over 50 authorized invention patents, and has received multiple honors such as "Specialized, Refined, and Innovative" enterprise and provincial technology center [1] Group 2 - Shuang'en Intelligent Technology, also a national high-tech enterprise, focuses on medical-grade metal additive manufacturing, establishing a complete industrial chain from equipment development to customized services [2] - The company has developed medical 3D printing equipment and provides titanium alloy implants and solutions, with a strong core team of 7 PhDs, including 4 national-level talents, and holds 37 authorized patents [2] - The establishment of these two companies as provincial doctoral innovation practice bases reflects the recognition of their research capabilities and talent platforms, contributing to the optimization of the innovation ecosystem in the region [2]

Core Viewpoint - Dane A. Miller, co-founder and long-time CEO of Biomet, demonstrated his commitment to the safety of titanium implants by personally having a titanium alloy implanted in his arm for ten years, which became a powerful testament to the trustworthiness of the materials used in orthopedic devices [3][10]. Group 1: Background and Education - Miller was born in Springfield, Ohio, and developed an early interest in engineering, eventually earning a bachelor's degree in mechanical engineering from Ohio State University and a master's and PhD in biomedical materials from the University of Cincinnati [6]. - His research focused on the biocompatibility of materials like titanium and tantalum, addressing the challenges of implant safety and integration with human bone [6]. Group 2: Founding Biomet - In 1977, Miller co-founded Biomet in Warsaw, Indiana, starting with a revenue of only $17,000 and operating from a converted barn [8]. - Unlike contemporaries that focused on mass production, Biomet emphasized custom implants tailored to surgeons' needs, quickly building a strong reputation in the industry [8]. - Under Miller's leadership from 1978 to 2006, Biomet grew to over $2 billion in annual revenue and employed more than 4,000 people, with flagship products like the AGC knee system setting industry standards [8]. Group 3: Trust through Personal Experience - To alleviate surgeons' concerns about the long-term safety of titanium implants, Miller had a titanium rod implanted in his arm, which he showcased at medical conferences, effectively using his experience as a marketing tool for Biomet [10]. - This personal experiment not only garnered attention but also established a narrative of trust and innovation around Biomet's products [10]. Group 4: Personal and Philanthropic Aspects - Miller's commitment to the field was personal, as his grandmother was the first patient to receive a total hip replacement from Biomet, highlighting the impact of his work on family and community [13]. - He and his wife established the Dr. Dane & Mary Louise Miller Foundation to support scholarships, community projects, and environmental initiatives [13]. Group 5: Legacy and Industry Impact - After stepping down in 2006 due to board conflicts, Miller regained control of Biomet in 2007 through a $11.4 billion acquisition with private equity partners [13]. - Biomet was acquired by Zimmer in 2015, forming Zimmer Biomet, and Miller passed away the same year, leaving behind a legacy as a pioneer in the orthopedic device industry [13]. - His approach combined trust and innovation, demonstrating the importance of risk-taking in advancing materials science and clinical practice [14].